US Court rules in favour of Mylan for Copaxone patents: Natco

In December 2016, the US Patent and Trademark Office (PTO) had ruled in favour of Mylan and three patents related to Copaxone 40 mg/mL were found unpatentable.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news